STEPHANIE FOLLETT: Open Payments
NPI 1912311929 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 22 payments from 12 companies in 2025. Trend: 2023 $221 · 2024 $211 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $162 |
| Astellas Pharma US Inc | 2 | $46 |
| Exact Sciences Corporation | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, QULIPTA, Veozah, Cologuard Collection Kit, GVOKE HYPOPEN, WATCHMAN Access System, t:slim X2 Insulin Pump with Control-IQ, YUPELRI.
Industry payments across ID — which companies pay providers there.
